Do you know the top 10 cities for stem cell searches on Google? It is an interesting question, because Google searches reflect individual interest in the topic. Furthermore, geographical data reflects hotspots where user interest is the greatest. Together, this data reflects important market dynamics within particular geographical areas.
In the analysis below, Google search data from 2004 to present is presented. This search was executed September 6, 2015, using the Google Trends tool. See the chart and map below to learn the top ten cities where users are searching online for topics about stem cells. The numbers shown represent search volumes relative to the highest search level identified, which is always 100.
Google currently represents over 70% of online search, which makes it an excellent resource for this stem cell analysis.
Visual Representation of the Findings
In the map below, the information is presented visually, showing large dark circles for the leading cities, and progressively smaller, lighter circles for the cities farther down the list.
Top Countries Represented by the Cities Above
In the data above, six of the ten top cities for stem cell searches on Google are within the United States. Seven of the ten top cities for stem cell searches are within North America, because the Canadian city of Toronto also makes the list. Two of the ten top cities for stem cell searches are within India, which are Chennai and Bangalore. The only other country that has qualified a city for this list is Singapore.
Clearly, the bulk of online searches about stem cells over the past ten years has occurred within the United States, with India having the second largest quantity.
For the top city, it is not surprising to see Boston, Massachusetts, win the honor, because it is a hub of stem cell research activity. It is home to the Whitehead Institute, Harvard University, Boston Biomedical, Ocata Therapeutics, ViaCord, and AMAG Pharmaceuticals, as well other renowned research institutions and leaders from across private industry.
About Us
BioInformant is the first and only market research firm to specialize exclusively in the stem cell industry. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, Medical Ethics, Vogue Magazine, and more. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry data.
Andrew Blidy says
Having pioneer the development of CD34+ as a commercial product back in the mid 1980″s at Becton Dickinson Monoclonal Center I know a couple of things about cell analysis….My #1 thing is potency and migration of stem cells and how it is evaluated today ….Premium cellular products comes from one source today blastomere pluripotent stem cells, “gold standard” …..Cord blood is analyzed with CD34/CD38 in flow cytometry data as fundamental practice …..
Blastomere pluripotent stem cells and adult derived stem cells should be measure by CD10 /CD24/Stro-1….. especially for MSC ….See Robert Lanza ‘s published paper on the subject……Ocata.com
My question is what are standards of iPSC from phenotype and geneotype …..Has anyone done this ? How do you measure iPSC for potency , migration and vascularity ?